Literature DB >> 1468431

In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogens.

A L Barry1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1468431     DOI： 10.1007/bf01960893

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.

Authors:  F H Kayser; G Morenzoni; P Santanam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

2.  Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.

Authors:  M Powell; D McVey; M H Kassim; H Y Chen; J D Williams
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

3.  Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.

Authors:  J H Jorgensen; G V Doern; L A Maher; A W Howell; J S Redding
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

4.  Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

5.  Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays.

Authors:  G V Doern; T A Tubert
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948
  5 in total
  5 in total

Review 1.  Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.

Authors:  C J Dunn; L B Barradell
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

2.  Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.

Authors:  A L Barry; P C Fuchs
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

3.  Susceptibility of bacterial respiratory pathogens to amoxicillin and amoxicillin-clavulanic acid.

Authors:  A L Barry; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

4.  Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis.

Authors:  R Hayle; E Lingaas; H O Høivik; T Odegård
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

Review 5.  Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.